Emphysema Completed Phase 2 / 3 Trials for Alpha-1-proteinase inhibitor (DB00058)

Also known as: Bullous emphysema (lung)(pulmonary) / Pulmonary Emphysema / Emphysema pulmonary

IndicationStatusPhase
DBCOND0019688 (Emphysema)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01217671International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With EmphysemaTreatment